Literature DB >> 30737653

Eugenol Attenuates Scopolamine-Induced Hippocampal Cholinergic, Glutamatergic, and Mitochondrial Toxicity in Experimental Rats.

Debapriya Garabadu1, Mahima Sharma2.   

Abstract

Eugenol is one of the essential chemical constituents of several functional food plants including Eugenia caryophyllata Thunb. (Family: Myrtaceae). Eugenol exhibits neuroprotective and anti-stress activities through multimodal mechanisms of action. Further, eugenol exerts anti-amnesic activity in Alzheimer's disease (AD)-like animals perhaps through anti-oxidant mechanism to date. Hence, the present study was designed to elaborate the anti-amnesic activity of eugenol in scopolamine-challenged rodents. Scopolamine (3 mg/kg/day, i.p.) and eugenol (12.5, 25.0, and 50.0 mg/kg) were administered to male rats for 14 consecutive days of the experimental schedule at a time lag of 30 min. Eugenol (25.0 and 50.0 mg/kg) attenuated scopolamine-induced loss in learning ability in terms of increased escape latency at day-4 (D-4) and memory function in terms of decreased time spent in target quadrant at D-5 of Morris water maze test protocol. Moreover, eugenol attenuated scopolamine-induced loss in spatial memory in terms of decreased percentage of spontaneous alteration behavior in Y-maze test. Additionally, eugenol attenuated scopolamine-induced hippocampal cholinergic dysfunction (decrease in acetylcholine level, increase in acetylcholinesterase activity, and decrease in density and affinity of M1 and total muscarinic receptor), glutamate neurotoxicity (increase in levels of glutamate, calcium, calcium-dependent calpain-2, and brain-derived neurotropic factor), and mitochondrial dysfunction (decrease in formazan produced, membrane potential, and oxidative stress) in rats. Thus, it could be considered as an alternate candidate in the management of AD. Moreover, inclusion of functional foods containing eugenol could be a better option to manage memory formation in neurological disorders.

Entities:  

Keywords:  Acetylcholine; Eugenol; Glutamate; Hippocampus; Memory; Mitochondria

Mesh:

Substances:

Year:  2019        PMID: 30737653     DOI: 10.1007/s12640-019-0008-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  42 in total

1.  Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.

Authors:  H Wang; J A Joseph
Journal:  Free Radic Biol Med       Date:  1999-09       Impact factor: 7.376

2.  Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum.

Authors:  S M Hersch; A I Levey
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

Review 3.  Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues.

Authors:  P L Pedersen; J W Greenawalt; B Reynafarje; J Hullihen; G L Decker; J W Soper; E Bustamente
Journal:  Methods Cell Biol       Date:  1978       Impact factor: 1.441

4.  Plant oils thymol and eugenol affect cattle and swine waste emissions differently.

Authors:  V H Varel; D N Miller; A D Lindsay
Journal:  Water Sci Technol       Date:  2004       Impact factor: 1.915

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.

Authors:  R F BEERS; I W SIZER
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

7.  Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.

Authors:  Matthew R Nangle; T Michael Gibson; Mary A Cotter; Norman E Cameron
Journal:  Planta Med       Date:  2006-05       Impact factor: 3.352

8.  Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice.

Authors:  S H Choi; C H Park; J W Koo; J H Seo; H S Kim; S J Jeong; J H Lee; S S Kim; Y H Suh
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

Review 9.  Treatment of Alzheimer's disease: current and future therapeutic approaches.

Authors:  Jeffrey L Cummings
Journal:  Rev Neurol Dis       Date:  2004

10.  Development of a high throughput screening assay for mitochondrial membrane potential in living cells.

Authors:  Shu-Gui Huang
Journal:  J Biomol Screen       Date:  2002-08
View more
  3 in total

1.  Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease.

Authors:  Giuseppa Mudò; Valentina Di Liberto; Domenico Nuzzo; Monica Frinchi; Costanza Giardina; Miriana Scordino; Mariachiara Zuccarini; Chiara De Simone; Marta Di Carlo; Natale Belluardo
Journal:  Cell Mol Neurobiol       Date:  2022-09-03       Impact factor: 4.231

2.  Therapeutic effects of eugenol in a rat model of traumatic brain injury: A behavioral, biochemical, and histological study.

Authors:  Jeetprakash Barot; Bhagawati Saxena
Journal:  J Tradit Complement Med       Date:  2021-01-08

3.  3-O-Acetyl-11-keto-β-boswellic acid ameliorates acquired, consolidated and recognitive memory deficits through the regulation of hippocampal PPAR γ, MMP9 and MMP2 genes in dementia model.

Authors:  Venkatesh Gunasekaran; Jinu Avarachan; Anitta Augustine; Abdul Khayum; Arivukkarasu R
Journal:  Heliyon       Date:  2021-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.